ObvioHealth, a US- and Singapore-based clinical trials provider, has raised $15 million in its latest funding round, according to filings with Singapore’s Accounting and Corporate Regulatory Authority (ACRA).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in